Pinned
$IBRX is up 200% year to date. Why?... Let me explain.
Anktiva is an IL-15 receptor agonist, similar in concept to GLP-1 receptor agonists. Both work by activating specific receptors to drive powerful biological outcomes. In this case, IL-15 signaling activates natural killer









